Core Insights - The Ensign Group, Inc. reported strong operating results for Q2 2025, with GAAP diluted earnings per share of $1.44, an 18.0% increase year-over-year, and adjusted earnings per share of $1.59, a 20.5% increase year-over-year [1][5][6]. Operating Results - The company achieved record occupancy rates of 82.1% for same facilities and 84.0% for transitioning facilities, reflecting increases of 2.0% and 4.6% respectively compared to the prior year [4][5]. - Skilled daily census increased by 7.4% for same facilities and 13.5% for transitioning facilities compared to the prior year [4][5]. - Total skilled services revenue reached $1.17 billion, marking an 18.4% increase year-over-year [5][38]. Financial Performance - GAAP net income for the quarter was $84.4 million, an 18.9% increase from the prior year, while adjusted net income was $93.3 million, a 22.1% increase [5][6]. - Consolidated revenue for the quarter was $1.23 billion, up 18.5% from the previous year [5][6]. - The company raised its annual earnings guidance for 2025 to between $6.34 and $6.46 per diluted share, reflecting a more than 16% increase over 2024 results [6][7]. Growth and Acquisitions - The company added 52 new operations since the beginning of 2024, with eight new operations added in the latest quarter [7][8]. - Ensign's portfolio now consists of 348 healthcare operations across 17 states, with 146 real estate assets owned [10][11]. - Recent acquisitions include several skilled nursing and senior living facilities in California and Idaho [9][15]. Dividend and Liquidity - The company declared a quarterly cash dividend of $0.0625 per share, continuing its long history of dividend payments [12]. - Ensign maintains strong liquidity with approximately $364.0 million in cash and $592.6 million available under its line of credit [7][12].

NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (the "Company") (TSX:STCK & TSX:STCK.WT.A) is pleased to announce the terms of a "best efforts" private placement and concurrent non-brokered private placement for aggregate gross proceeds to the Company of up to $25,000,000 (the "Offering"). In connection with the Offering, the Company announces that it has entered into an agreement with ...

ZUG, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced the closing of its previously announced upsized underwritten public offering of 9,562,500 ordinary shares (which includes the ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its fourth quarter and fiscal year 2025 financial results before the U.S. stock market opens on Thursday, August 7, 2025. The company will host a conference call and live audio webcast to discuss the financial results at 8:30 a.m. (Eastern Time) that day. Peloton’s management will answer select questions from retail and institutional investors that are related to the company’s business updates and quarterly fin ...

MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants ...

CERRITOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2025 financial results after the market close on Wednesday, August 13, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-6 ...

PONTE VEDRA, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that it will release financial results for the second quarter 2025 after the close of trading on Thursday, August 7, 2025. Company management will host a conference call to disc ...

US Sales down in the Quarter; Rest of World up First-half Toy/Consumer Products sales flat to prior year SANTA MONICA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK) today reported financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Net sales were $119.1 million, a year-over-year decrease of $29.5 million or 20%, driven largely by a reduction in direct-import sales due to higher cost of importation US net sales were $87.0 million, down 31% compared ...

Company to share primary endpoint results at 32-Weeks from Extension phase following late-breaking presentations at Alzheimer's Association International Conference® (AAIC) 2025 Conference call and webcast to be held Monday, July 28 at 8:00 AM ET BOSTON, July 24, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that the Company will host a conference call and webcast on Monday, July 28 at 8: ...

VERO BEACH, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- (July 24, 2025) – Orchid Island Capital, Inc. (NYSE:ORC) ("Orchid” or the "Company"), a real estate investment trust ("REIT"), today announced results of operations for the three month period ended June 30, 2025. Second Quarter 2025 Results Net loss of $33.6 million, or $0.29 per common share, which consists of:Net interest income of $23.2 million, or $0.20 per common shareTotal expenses of $5.0 million, or $0.04 per common shareNet realized and unrealized ...